BCL10 |
BCL10, CIPER, CLAP: B-cell lymphoma/leukemia 10 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
24.100 |
Evidence |
|
CARD4 |
NOD1, CARD4: Nucleotide-binding oligomerization domain-containing protein 1 |
NALP1 |
NLRP1, CARD7, DEFCAP, KIAA0926, NAC, NALP1: NACHT, LRR and PYD domains-containin |
24.100 |
Evidence |
|
ID4 |
ID4: DNA-binding protein inhibitor ID-4 |
HES6 |
HES6: Transcription cofactor HES-6 |
24.100 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
MYOG |
MYOG, MYF4: Myogenin |
24.100 |
Evidence |
|
DEDD |
DEDD, DEDPRO1, KE05, DEFT: Death effector domain-containing protein |
DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
24.100 |
Evidence |
|
CARD12 |
NLRC4, CARD12, UNQ6189/PRO20215, CLAN, CLAN1, IPAF: NLR family CARD domain-conta |
CARD11 |
CARD11, CARMA1: Caspase recruitment domain-containing protein 11 |
24.100 |
Evidence |
|
ID1 |
ID1, ID: DNA-binding protein inhibitor ID-1 |
HES6 |
HES6: Transcription cofactor HES-6 |
24.100 |
Evidence |
|
HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
24.100 |
Evidence |
|
BIK |
BIK, NBK: Bcl-2-interacting killer |
BOK |
BOK: Bcl-2-related ovarian killer protein |
24.100 |
Evidence |
|
CACNA1G |
IPI00219398 |
KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
24.100 |
Evidence |
|
TNFRSF25 |
TNFRSF25, APO3, UNQ455/PRO779, DDR3, DR3, TNFRSF12, WSL, WSL1: Tumor necrosis fa |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
24.100 |
Evidence |
|
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
LTB |
LTB, TNFC, TNFSF3: Lymphotoxin-beta |
24.100 |
Evidence |
|
KCNQ4 |
KCNQ4: Potassium voltage-gated channel subfamily KQT member 4 |
HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
24.100 |
Evidence |
|
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
BAK1 |
IPI00003352 |
24.100 |
Evidence |
|
APAF1 |
IPI00023630 |
BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
24.100 |
Evidence |
|
NALP13 |
NLRP13, NALP13, NOD14: NACHT, LRR and PYD domains-containing protein 13 |
CARD11 |
CARD11, CARMA1: Caspase recruitment domain-containing protein 11 |
24.100 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
PRSS36 |
PRSS36: Polyserase-2 precursor |
24.100 |
Evidence |
|
PSMB2 |
PSMB2: Proteasome subunit beta type-2 |
PSMB5 |
PSMB5, LMPX: Proteasome subunit beta type-5 precursor |
24.100 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
24.100 |
Evidence |
|
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
24.100 |
Evidence |
|
CACNA1H |
CACNA1H: Voltage-dependent T-type calcium channel subunit alpha-1H |
SCN8A |
SCN8A, MED: Sodium channel protein type 8 subunit alpha |
24.100 |
Evidence |
|
PKD2L1 |
PKD2L1, PKD2L, PKDL: Polycystic kidney disease 2-like 1 protein |
SCN10A |
SCN10A, PN3: Sodium channel protein type 10 subunit alpha |
24.100 |
Evidence |
|
TNFSF9 |
TNFSF9: Tumor necrosis factor ligand superfamily member 9 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
24.100 |
Evidence |
|
FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
24.080 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
K-ALPHA-1 |
TUBA1B: Tubulin alpha-1B chain |
24.080 |
Evidence |
|